Logo Logo
Hilfe
Hilfe
Switch Language to English

Habler, Katharina; Brügel, Mathias; Teupser, Daniel; Liebchen, Uwe; Scharf, Christina; Schönermarck, Ulf; Vogeser, Michael und Paal, Michael (2021): Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum. In: Journal of Pharmaceutical and Biomedical Analysis, Bd. 196, 113935

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Background: The present COVID-19 pandemic has prompted worldwide repurposing of drugs. The aim of the present work was to develop and validate a two-dimensional isotope-dilution liquid chromatrography tandem mass spectrometry (ID-LC-MS/MS) method for accurate quantification of remdesivir and its active metabolite GS-441524, chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin in serum;drugs that have gained attention for repurposing in the treatment of COVID-19. Methods: Following protein precipitation, samples were separated with a two-dimensional ultra-high performance liquid chromatography (2D-UHPLC) setup, consisting of an online solid phase extraction (SPE) coupled to an analytical column. For quantification, stable isotope-labelled analogues were used as internal standards for all analytes. The method was validated on the basis of the European Medicines Agency bioanalytical method validation protocol. Results: Detuning of lopinavir and ritonavir allowed simultaneous quantification of all analytes with different concentration ranges and sensitivity with a uniform injection volume of 5 mu L. The method provided robust validation results with inaccuracy and imprecision values of <= 9.59 % and <= 11.1 % for all quality controls. Conclusion: The presented method is suitable for accurate and simultaneous quantification of remdesivir, its metabolite GS-441525, chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin in human serum. The quantitative assay may be an efficient tool for the therapeutic drug monitoring of these potential drug candidates in COVID-19 patients in order to increase treatment efficacy and safety. (C) 2021 Elsevier B.V. All rights reserved.

Dokument bearbeiten Dokument bearbeiten